To better contain epidemics, we need to build new tools to detect disease faster and simpler. Improving technology, platforms, and tests could revolutionize how first responders react to deadly outbreaks to accelerate diagnosis, inform quarantine deliberations, and improve tailored medical treatments to save both lives and money.
Experts at Columbia are conducting crucial precision medicine research around microbe surveillance, discovery, and diagnosis using a variety of innovative tools to improve how governments, scientists, and communities address global epidemics. Viruses and disease research range broadly, including HIV, influenza, ebola, measles, zika, and COVID-19.
Learn more about how the Center for Infection and Immunity and Dr. Ian Lipkin are developing tests to identify different virus type, Columbia ICAP is improving the health of communities in over 30 countries, and the Center for the AIDS Programming of Research in South Africa (CAPRISA) is improving HIV testing and outcomes. In addition to these groups, individual labs are expanding precision capabilities of infectious disease research, including Dr. Micaela Martinez and Dr. Jeffrey Shaman’s computer modeling different diseases and the COVID-19 outbreak, Dr. Brent William’s work on the microbiome, and Dr. Wan Yang’s research on influenza, ebola, and COVID-19.
